newsTherapy approved for patients with sickle cell disease complication18 November 2019 | By Rachael Harper (European Pharmaceutical Review)Adakveo has been approved by the FDA to reduce the frequency of vaso-occlusive crisis, a painful complication of sickle cell disease.